Tag: investment
-
Cosmetic Dentistry – A Worthy Investment In 2018?
The demand for cosmetic dentistry is still very much there, and the industry is experiencing different trends and developments in technology that is keeping the market growing.
-
Pfizer, Biotech Partner on RNA Flu Vaccine
A biotechnology company in Germany and drug maker Pfizer are developing a vaccine to prevent seasonal influenza using messenger RNA that instructs cells on production of proteins.
-
Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million
A new company is forming to develop treatments that protect against destruction of brain cells in Alzheimer’s disease and comparable nerve damage from chemotherapy.
-
Infographic – U.S. Falling Way Behind on 5G
The success of mobile devices depends on their underlying technologies, with the next generation of mobile standards known as 5G in the queue.
-
Start-Up Developing Regenerative Liver Disease Treatments
A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions.
-
Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal
Two biotechnology companies with complementary technologies plan to create treatments for cancer that harness and modify cells from the immune system delivered with benign viruses.
-
Infographic – Harvard or Stanford? Venture Capitalists Revealed.
Our reporting on venture capital, much like other business media, tells about the companies investing in early-stage enterprises, but what about the people in the industry?
-
Univ. Spin-Off Developing Myelin Disease Treatments Unveiled
A spin-off enterprise from Case Western Reserve University is developing therapies designed to restore the myelin sheath around nerve cells destroyed in multiple sclerosis and other neurological disorders.
-
GSK, 23andMe Ink Precision Meds Discovery Deal
Consumer genetics company 23andMe signed a 4-year agreement to help drug maker GlaxoSmithKline find more precise drug targets and recruit clinical trial participants likely to respond to treatments.
-
Gates, Lauder Backing Early Alzheimer’s Biomarker Tests
A group of well-known philanthropists is backing a new research program to find simple tests that reveal early indicators of Alzheimer’s disease in a person’s molecular make-up.